English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Many men live with chronic prostate diseases, such as Benign Prostatic Hyperplasia (BPH) and Chronic Prostatitis/Chronic Pelvic Pain Syndrome (CP/CPPS). Medications widely prescribed for BPH and CP/CPPS can cause sexual dysfunction and depression, which may increase patient visits to hospitals. The purpose of this study is to determine whether Thermobalancing Therapy (TT) and Dr. Allen??s Therapeutic Device (DATD) can be used as the first-line treatment preventing the development of new health disorders often resulting from taking medications for BPH and CP/CPPS. Methods: This is a retrospective analysis of 2 observational clinical trials on Thermobalancing Therapy and DATD. Cohorts of 124 men with BPH and 45 men with CP/CPPS were treated with DATD and compared to the control groups without DATD. The dynamics of pain, urinary symptoms, Quality of Life (QoL), and Prostate Volume (PV) were assessed before and after treatment. Results: In men with Benign Prostatic Hyperplasia (BPH), Dr. Allen??s Therapeutic Device (DATD) reduced PV from 45ml to 31ml (P<0.001) and decreased urinary symptoms from 14.3 to 4.9 (P<0.001). DATD reduced pain score from 10.3 to 3.5 (P<0.001) in men with Chronic Prostatitis/Chronic Pelvic Pain Syndrome (CP/CPPS). QoL was improved in both treatment groups. In the control groups, no positive changes were observed. Conclusions: The use of Thermobalancing therapy as a monotherapy reduces the abnormal prostate size and provides chronic pelvic pain relief in men with BPH and CP/CPPS, improving their QoL. This at-home treatment with DATD reduces the need for long-term courses of BPH and CP/CPPS medications preventing retrograde ejaculation, sexual dysfunction, depression, and other health disorders. The wider use of DATD in healthcare systems will decrease male visits to hospitals, diminishing the risks of contracting a viral infection and transmitting it to others during a coronavirus outbreak or another pandemic. Keywords: Benign prostatic hyperplasia; Chronic prostatitis; Thermobalancing therapy; Chronic pelvic pain; Dr. Allen??s device; Medications; Side effects; Alpha-blockers; 5α-reductase inhibitors Abbreviations: TT: Thermobalancing Therapy; DATD: Therapeutic Dr. Allen??s Device; BPH: Benign Prostatic Hyperplasia; CP/CPPS: Chronic Prostatitis/Chronic Pelvic Pain Syndrome; QoL: Quality of Life; PV: Prostate Volume; LUTS: Lower Urinary Tract Symptoms; I-PPS: International Prostate Symptom Scale; NIH-CPSI: National Institutes of Health Chronic Prostatitis Symptom Index; UrS: Urinary Symptoms; 5-ARIs: 5α-Reductase Inhibitors

Benign Prostatic Hyperplasia and Chronic Prostatitis Thermobalancing Therapy Can Prevent Sexual Dysfunction and Depression Linked to Medications: Importance During a Pandemic